Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia

European Heart Journal

Volumn 27, Issue 1, 2006, Pages 89-95

  Abello, Mauricio ^a   Merino, José L ^a   Peinado, Rafael ^a   Gnoatto, Mariana ^a   Arias, Miguel A ^a   Gonzalez Vasserot, Mar ^a   Sobrino, José A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Defibrillation; Syncope; Tachyarrhythmias

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEFIBRILLATOR; DEGENERATION; ENERGY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART PROARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; INCIDENCE; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SYNCOPE;

COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS;

EID: 28944448285     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi500     Document Type: Article

References (22)

1. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
2. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754.
3. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, Garson A Jr, Harvey JC, Kidwell GA, Klein GJ, Levine PA, Marchlinski FE, Prystowsky EN, Wilkoff BL. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996;94:1147-1166.
4. Jung W, Anderson M, Camm AJ, Jordaens L, Petch MC, Rosenqvist M, Santini M, Luderitz B. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J 1997;18:1210-1219.
5. Pires LA, May LM, Ravi S, Parry JT, Lal VR, Nino CL. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter- defibrillators. Am J Cardiol 2000;85:725-728.
6. Garcia-Moran E, Mont L, Cuesta A, Matas M, Brugada J. Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator. Eur Heart J 2002;23:901-907.
7. Leite LR, Fenelon G, Paes AT, de Paola AA. The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic chagasic heart disease. Arq Bras Cardiol 2001;77:439-452.
8. Josephson ME. Recurrent ventricular tachycardia. In: Josephson ME, ed. Clinical Cardiac Electrophysiology: Techniques and Interpretations. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p.425-610.
9. Peinado R, Almendral J, Rius T, Moya A, Merino JL, Martinez-Alday J, Perez-Villacastin J, Arenal A, Ormaetxe J, Tercedor L, Medina O, Pastor A, Delcan J. Randomized, prospective comparison of four burst pacing algorithms for spontaneous ventricular tachycardia. Am J Cardiol 1998;82:1422-1429.
10. Schaumann A, von zur MF, Herse B, Gonska BD, Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 1998;97:66-74.
11. Kou WH, Calkins H, Lewis RR, Bolling SF, Kirsch MM, Langberg JJ, de Buitleir M, Sousa J, el Atassi R, Morady F. incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med 1991;115:942-945.
12. Bansch D, Brunn J, Castrucci M, Weber M, Gietzen F, Borggrefe M, Breithardt G, Block M. Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 1998;31:608-615.
13. Pezawas T, Stix G, Kastner J, Wolzt M, Mayer C, Moertl D, Schmidinger H. Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy. Europace 2003;5:305-312.
14. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995;92:1651-1664.
15. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796-801.
16. Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999;33:1964-1970.
17. Olatidoye AG, Verroneau J, Kluger J. Mechanisms of syncope in implantable cardioverter-defibrillator recipients who receive device therapies. Am J Cardiol 1998;82:1372-1376.
18. Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999;34:1082-1089.
19. Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, Pires LA, Schuger CD, Steinman RT, Mosteller RD, Palti AJ, David JB, Lessmeier TJ, Lehmann MH. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 1997;8:1087-1097.
20. Landolina M, Mantica M, Pessano P, Manfredini R, Foresti A, Schwartz PJ, De Ferrari GM. Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. J Am Coll Cardiol 1997;29:568-575.
21. Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med 2001;345:391-397.
22. Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE, Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1995;26:180-184.